Medical director of angioline company Oleg Volkov made a report at the conference held at pavlov first saint petersburg state medical university
The V All-Russian Conference with international participation on Urgent Issues of Preclinical and Clinical Studies of Pharmaceuticals and Biomedical Cellular Products, and Clinical Studies of Medical Devices, arranged by Pavlov First Saint Petersburg State
Medical University, took part on June from 1 to 2, 2017 in St. Petersburg.
Within the framework of the symposium dedicated to the urgent issues of the clinical studies of medical device, Oleg Volkov, Medical Director of ANGIOLINE company, made a report on Importance and Peculiarities of Clinical Studies into Coronary Stents for Creation of the Evidential Base for Their Application in RF.
Every year, the Conference on Urgent Issues of Preclinical and Clinical Studies of Pharmaceuticals and Biomedical Cellular Products, and Clinical Studies of Medical Devices gathers the top-level manufacturers of pharmaceutical and medical devices, scientists and researchers, as well as managers of the health care administrative bodies of the RF regions, and representatives of the contract research organisation.
Watch the video of Oleg Volkov’s report on 4:49:48.